Concepts (82)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognition Disorders | 2 | 2015 | 243 | 0.680 |
Why?
|
| Sexual Behavior, Animal | 4 | 2012 | 64 | 0.670 |
Why?
|
| Social Behavior | 4 | 2012 | 161 | 0.620 |
Why?
|
| Anabolic Agents | 2 | 2009 | 20 | 0.580 |
Why?
|
| Aggression | 2 | 2009 | 102 | 0.550 |
Why?
|
| Testosterone | 3 | 2012 | 211 | 0.400 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 196 | 0.400 |
Why?
|
| Dendritic Spines | 2 | 2011 | 35 | 0.390 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 299 | 0.390 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 220 | 0.390 |
Why?
|
| Cognition | 2 | 2023 | 473 | 0.380 |
Why?
|
| Cyclophosphamide | 3 | 2025 | 59 | 0.380 |
Why?
|
| Doxorubicin | 3 | 2025 | 97 | 0.360 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2011 | 192 | 0.350 |
Why?
|
| Cocaine | 2 | 2011 | 251 | 0.330 |
Why?
|
| Steroids | 1 | 2009 | 45 | 0.310 |
Why?
|
| Antineoplastic Agents | 2 | 2025 | 1019 | 0.210 |
Why?
|
| Hippocampus | 2 | 2019 | 594 | 0.200 |
Why?
|
| Prefrontal Cortex | 1 | 2025 | 164 | 0.200 |
Why?
|
| Mesocricetus | 4 | 2012 | 56 | 0.190 |
Why?
|
| Anxiety | 1 | 2010 | 874 | 0.190 |
Why?
|
| Cricetinae | 4 | 2012 | 241 | 0.180 |
Why?
|
| DNA Methylation | 1 | 2025 | 403 | 0.180 |
Why?
|
| Age Factors | 3 | 2015 | 1154 | 0.160 |
Why?
|
| Sexual Maturation | 2 | 2012 | 24 | 0.160 |
Why?
|
| Rats | 4 | 2025 | 3735 | 0.160 |
Why?
|
| Menthol | 1 | 2020 | 23 | 0.160 |
Why?
|
| Faculty | 1 | 2020 | 105 | 0.150 |
Why?
|
| Analysis of Variance | 3 | 2011 | 575 | 0.150 |
Why?
|
| Animals | 9 | 2025 | 16992 | 0.150 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2020 | 95 | 0.150 |
Why?
|
| Schools, Medical | 1 | 2020 | 208 | 0.140 |
Why?
|
| Students, Medical | 1 | 2020 | 158 | 0.140 |
Why?
|
| Androgens | 2 | 2023 | 106 | 0.120 |
Why?
|
| Rats, Inbred SHR | 1 | 2015 | 30 | 0.120 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2015 | 81 | 0.110 |
Why?
|
| Behavior, Animal | 2 | 2015 | 373 | 0.110 |
Why?
|
| Neurons | 2 | 2012 | 1263 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 200 | 0.100 |
Why?
|
| Neuronal Plasticity | 1 | 2015 | 126 | 0.100 |
Why?
|
| Inflammation | 1 | 2019 | 758 | 0.100 |
Why?
|
| Prostatic Neoplasms | 1 | 2023 | 1092 | 0.100 |
Why?
|
| Female | 7 | 2025 | 24698 | 0.100 |
Why?
|
| Smoking Cessation | 1 | 2020 | 590 | 0.100 |
Why?
|
| Oxidative Stress | 1 | 2019 | 1003 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2019 | 1766 | 0.100 |
Why?
|
| Smoking | 1 | 2020 | 1024 | 0.100 |
Why?
|
| Animals, Newborn | 2 | 2011 | 352 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2015 | 561 | 0.090 |
Why?
|
| Amygdala | 1 | 2012 | 125 | 0.090 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2011 | 83 | 0.080 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2010 | 23 | 0.080 |
Why?
|
| Postpartum Period | 1 | 2011 | 92 | 0.080 |
Why?
|
| Seminal Vesicles | 1 | 2009 | 9 | 0.080 |
Why?
|
| Male | 6 | 2023 | 23409 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2019 | 2157 | 0.080 |
Why?
|
| Maze Learning | 1 | 2010 | 113 | 0.080 |
Why?
|
| Visual Perception | 1 | 2010 | 80 | 0.080 |
Why?
|
| Memory | 1 | 2010 | 174 | 0.070 |
Why?
|
| Testis | 1 | 2009 | 207 | 0.070 |
Why?
|
| Dominance-Subordination | 1 | 2007 | 6 | 0.070 |
Why?
|
| Nandrolone | 1 | 2007 | 7 | 0.070 |
Why?
|
| Pregnancy | 2 | 2011 | 1772 | 0.070 |
Why?
|
| Motor Activity | 1 | 2010 | 437 | 0.070 |
Why?
|
| Drug Interactions | 1 | 2007 | 150 | 0.070 |
Why?
|
| Sex Factors | 1 | 2010 | 1028 | 0.060 |
Why?
|
| Brain | 2 | 2011 | 1472 | 0.060 |
Why?
|
| Androgen Antagonists | 1 | 2023 | 29 | 0.050 |
Why?
|
| Epigenesis, Genetic | 1 | 2025 | 291 | 0.050 |
Why?
|
| Exercise Therapy | 1 | 2023 | 87 | 0.050 |
Why?
|
| Chemokines | 1 | 2019 | 96 | 0.040 |
Why?
|
| Exercise | 1 | 2023 | 692 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 532 | 0.030 |
Why?
|
| Prevalence | 1 | 2020 | 1612 | 0.030 |
Why?
|
| Mice | 1 | 2025 | 6644 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 1070 | 0.030 |
Why?
|
| Humans | 3 | 2023 | 43102 | 0.020 |
Why?
|
| Cell Count | 1 | 2012 | 145 | 0.020 |
Why?
|
| Silver Staining | 1 | 2011 | 7 | 0.020 |
Why?
|
| Aged | 1 | 2023 | 8214 | 0.020 |
Why?
|
| United States | 1 | 2020 | 5205 | 0.020 |
Why?
|
| Time Factors | 1 | 2009 | 1857 | 0.010 |
Why?
|